95 related articles for article (PubMed ID: 24911126)
21. Fragile X and company: finding the right diagnosis.
Subramony SH; Friedrich CA; Jankowiak J
Neurology; 2005 Jul; 65(2):E3-4. PubMed ID: 16043779
[No Abstract] [Full Text] [Related]
22. OPathPaed service model for expanded newborn screening in Hong Kong SAR, China.
Mak CM; Lam C; Siu W; Law C; Chan W; Lee HC; Chong Y; Chen SP; Ching C; Wong C; Lee M; Chow K; Lee K; Chan W; Chan K; Lee SY; Chan YW
Br J Biomed Sci; 2013; 70(2):84-8. PubMed ID: 23888612
[No Abstract] [Full Text] [Related]
23. Health supervision for children with fragile X syndrome.
Hersh JH; Saul RA;
Pediatrics; 2011 May; 127(5):994-1006. PubMed ID: 21518720
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis and fragile X syndrome: the arguments for antenatal screening.
Murray J; Cuckle H
Comb Chem High Throughput Screen; 2001 May; 4(3):265-72. PubMed ID: 11375741
[TBL] [Abstract][Full Text] [Related]
25. American Academy of Pediatrics, Committee on Genetics: Issues in newborn screening.
Pediatrics; 1992 Feb; 89(2):345-9. PubMed ID: 1530685
[No Abstract] [Full Text] [Related]
26. Molecular genetic screening in cytogenetically normal mentally retarded males with manifestations of fragile X syndrome.
Butler MG; Pratesi R; Vnencak-Jones CL
Am J Med Genet; 1994 Jul; 51(4):315-6. PubMed ID: 7942993
[No Abstract] [Full Text] [Related]
27. Challenges in prenatal screening and counselling for fragile X syndrome.
Mak AS; Leung KY
Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
[No Abstract] [Full Text] [Related]
28. Newborn screening for cystic fibrosis: can one algorithm fit all?
Caggana M
Expert Rev Mol Diagn; 2017 Mar; 17(3):205-207. PubMed ID: 28127999
[No Abstract] [Full Text] [Related]
29. Diagnosis and screening of fragile X syndrome: experiences in Taiwan.
Lin SJ
Acta Paediatr Taiwan; 2004; 45(2):67-8. PubMed ID: 15335112
[No Abstract] [Full Text] [Related]
30. Pediatricians' attitudes toward expanding newborn screening.
Acharya K; Ackerman PD; Ross LF
Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
[TBL] [Abstract][Full Text] [Related]
31. Fragile X syndrome.
Welch JL; Williams JK
Neonatal Netw; 1999 Sep; 18(6):15-22. PubMed ID: 10690095
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of prenatal population screening for fragile X syndrome.
Hollingsworth B; Harris A
Community Genet; 2005; 8(2):68-72. PubMed ID: 15925881
[TBL] [Abstract][Full Text] [Related]
33. A new approach to antenatal screening for Fragile X syndrome.
Wald NJ; Morris JK
Prenat Diagn; 2003 Apr; 23(4):345-51. PubMed ID: 12673644
[TBL] [Abstract][Full Text] [Related]
34. Pilot study for the neonatal screening of fragile X syndrome.
Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
[TBL] [Abstract][Full Text] [Related]
35. Case finding for the fragile X syndrome and its consequences.
Turner G; Robinson H; Wake S; Laing S; Partington M
BMJ; 1997 Nov; 315(7117):1223-6. PubMed ID: 9393231
[No Abstract] [Full Text] [Related]
36. [More specific analyses in neonatal screening using DNA techniques].
Larsson A
Lakartidningen; 2002 Apr; 99(17):1927-8. PubMed ID: 12043414
[No Abstract] [Full Text] [Related]
37. Fragile X syndrome testing in the North West.
Smith K; Chandler K; Hindley D; Ramsden SC
Arch Dis Child; 2013 Mar; 98(3):239. PubMed ID: 23334255
[No Abstract] [Full Text] [Related]
38. [Screening for Fragile X syndrome mutations during early pregnancy--results and mothers' opinions about the gene test].
Ryynänen M; Heinonen S; Makkonen M; Mannermaa A; Kirkinen P
Duodecim; 1998; 22(114):2323-9. PubMed ID: 11757093
[No Abstract] [Full Text] [Related]
39. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
McConkie-Rosell A; Abrams L; Finucane B; Cronister A; Gane LW; Coffey SM; Sherman S; Nelson LM; Berry-Kravis E; Hessl D; Chiu S; Street N; Vatave A; Hagerman RJ
J Genet Couns; 2007 Oct; 16(5):593-606. PubMed ID: 17497108
[TBL] [Abstract][Full Text] [Related]
40. Policy considerations in designing a fragile X population screening program.
Ross LF; Acharya K
Genet Med; 2008 Oct; 10(10):711-3. PubMed ID: 18813132
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
